Industry top-down
Medical Devices
Latest reported revenue & EPS across the covered companies in this industry, with year-over-year (YoY) change. From disclosed earnings — not investment advice.
AI industry top-down
The medical device industry generally experienced robust sales growth. Many companies recorded double-digit sales growth rates, reflecting the industry's vitality. However, individual company performance varied, with some firms experiencing a decline in EPS despite strong sales growth. Notably, EPS growth rates exhibited significant disparities across companies, indicating a mixed picture regarding profitability. While overall sales growth was positive, profitability metrics varied distinctly across companies.
- Most companies show robust revenue growth
- Some companies record high revenue growth rates
- Significant disparity in EPS growth rates across companies
AI synthesis of disclosed results and analyst research across these companies — not investment advice.
Companies — latest quarter
| Company | Period | Revenue | Rev YoY | EPS | EPS YoY | Surprise |
|---|---|---|---|---|---|---|
| ABTABBOTT LABORATORIES | FY2026 Q1 | $11.16B | +7.8% | $0.61 | -19.7% | — |
| MDTMedtronic plc | FY2027 Q1 | $9.76B | +13.7% | $1.14 | +40.7% | — |
| SYKSTRYKER CORP | FY2026 Q2 | $6.59B | +9.4% | $3.30 | +44.1% | — |
| BSXBOSTON SCIENTIFIC CORP | FY2026 Q2 | $5.44B | +7.5% | $0.61 | +15.1% | — |
| EWEdwards Lifesciences Corp | FY2026 Q2 | $1.74B | +13.6% | $0.42 | -25.0% | — |
| DXCMDEXCOM INC | FY2026 Q2 | $1.31B | +13.1% | $0.64 | +42.2% | — |
| GEHCGE HealthCare Technologies Inc. | FY2026 Q1 | $5.13B | +7.4% | $0.85 | -30.9% | — |
| STESTERIS plc | FY2026 Q3 | $1.5B | +9.2% | $1.96 | +12.0% | — |
| ZBHZIMMER BIOMET HOLDINGS, INC. | FY2026 Q2 | $2.18B | +4.8% | $1.03 | +33.8% | — |
| PENPenumbra Inc | FY2026 Q2 | $390.05M | +14.9% | $0.88 | -23.5% | — |
| TXG10x Genomics, Inc. | FY2026 Q2 | $151.04M | -12.6% | $-0.14 | — | — |
| BIOBIO-RAD LABORATORIES, INC. | FY2026 Q2 | $651M | -0.1% | $13.85 | +18.7% | — |
| GMEDGLOBUS MEDICAL INC | FY2026 Q2 | $789.61M | +5.9% | $1.10 | -26.2% | — |
| BRKRBRUKER CORP | FY2026 Q2 | $838.5M | +5.2% | $-0.41 | — | — |
| BIO-BBIO-RAD LABORATORIES, INC. | FY2026 Q2 | $651M | -0.1% | $13.85 | +18.7% | — |
| PODDINSULET CORP | FY2026 Q2 | $801.7M | +23.5% | $1.37 | — | — |
| MASIMASIMO CORP | FY2026 Q1 | $372M | +9.5% | $-3.12 | — | — |
| GKOSGLAUKOS Corp | FY2026 Q2 | $185.61M | +49.5% | $-0.31 | — | — |
| HAEHAEMONETICS CORP | FY2027 Q1 | $339.38M | +5.6% | $0.72 | +2.9% | — |
| ITGRInteger Holdings Corp | FY2026 Q2 | $464.11M | -2.6% | $0.69 | -33.7% | — |
| LIVNLivaNova PLC | FY2026 Q2 | $390.59M | +10.8% | $1.93 | +286.0% | — |
| IRTCiRhythm Holdings, Inc. | FY2026 Q2 | $224.17M | +20.1% | $-0.01 | — | — |
| NEOGNEOGEN CORP | FY2026 Q3 | $211.2M | -4.4% | $-0.08 | — | — |
| TMDXTransMedics Group, Inc. | FY2026 Q2 | $189.95M | +20.7% | $0.41 | -55.4% | — |
| AXGNAxogen, Inc. | FY2026 Q2 | $69.73M | +23.1% | $-0.03 | — | — |
| BFLYButterfly Network, Inc. | FY2026 Q2 | $32.61M | +39.5% | $-0.05 | — | — |
| UFPTUFP TECHNOLOGIES INC | FY2026 Q2 | $173.96M | — | $2.68 | — | — |
| ALMRAlamar Biosciences, Inc. | FY2026 Q2 | $29.43M | — | $-0.22 | — | — |
| INSPInspire Medical Systems, Inc. | FY2026 Q2 | $200.58M | -7.6% | $0.01 | — | — |
| ESTAESTABLISHMENT LABS HOLDINGS INC. | FY2026 Q2 | $67.54M | +31.7% | $-0.39 | — | — |
| NVCRNovoCure Ltd | FY2026 Q2 | $183.58M | +15.6% | $-0.13 | — | — |
| 214150CLASSYS Inc. | FY2026 Q2 | ₩105.52B | +26.7% | ₩434.00 | +8.2% | — |
YoY = vs. the same quarter last year · Surprise = EPS actual vs. consensus. Latest reported quarter per company, from disclosed earnings filings. QoQ is omitted because quarterly filings don’t break out Q4 (US) and report cumulatively (KR).